Details for 2011790495
Up to date per 06.04.2026
Actions
Details for 2011790495
Granted/Registered
European Patent
10.04.2013 A
18.07.2018 B1
03.06.2010
US
351125 P
13.04.2011
US
201161474764 P
07.01.2011
US
201161430645 P
A61K 39/395 20060101AFI20131029BHEP
Owner
AbbVie Biotechnology LtdClarendon House 2, Church Street HM 11 HamiltonBM
Representative
Representative
Kliment & Henhapel Patentanwälte OGGonzagagasse 151010 WienAT
Inventor
OKUN, Martin, M.207 W. Park Avenue Libertyville, IL 60048US
HARRIS, Thomas, C.432 Saint Andrews Lane Gurnee, IL 60031US
Information about Fees